Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Asia Pacific In-vitro Diagnostics Market: By Product and Service: Reagents and Kits, Instruments, Software and Services; By Technology; By Application; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Asia Pacific In-vitro Diagnostics Market Outlook

The Asia Pacific in-vitro diagnostics market is expected to grow at a CAGR of 5.2% during the period 2022-2027. In-vitro diagnostics can help identify early warning signs and individual risk factors, generating new openings for prevention and early intervention. Some in-vitro diagnostics range beyond the laboratory, hospital or doctor’s office, enabling patients with chronic illnesses to self-monitor and manage their own conditions. Several leading companies offer in-vitro diagnostic (IVD) solutions that deliver rapid, sensitive results while minimizing cost and complexity. Modern in-vitro diagnostics (IVDs) enable better diagnosis for prevention and management of infectious and chronic diseases. These factors are expected to drive market growth.

 

Market Likely to be Driven by Demand for Quality Medical Care and Improving Healthcare Infrastructure

Leading in-vitro diagnostics companies seek growth helpful to business plans; regions such as Asia Pacific offer significant market potential. In developing countries, rising levels of income and standards of living are expected to stimulate a new, health-conscious populace seeking quality medical care. Expanding healthcare infrastructure and improved quality of healthcare in countries like India are likely to be driving factors of the Asia Pacific in-vitro diagnostics market. Major companies like Fujifilm offer solutions based on the company’s dry chemistry technology; such solutions help medical practitioners who need immediate and dependable results for early patient treatment and care. The company offers high quality diagnostic reagents and tests. Solutions include:

Beta-Glucan Test - The Toxinometer MT-6500 based β-Glucan Test is an in vitro diagnostic test for the quantitative determination of (1→3)-β-D-glucan in serum or plasma.

µTASWako™ AFP-L3 Test - An in vitro diagnostic blood test for the risk assessment of developing Hepatocellular Carcinoma (HCC).

Autokit CH50 Assay - An in vitro diagnostic (IVD) test for the quantitative determination of total complement activity in human serum.

Total Bilirubin L-Type Assay - An in vitro diagnostic (IVD) test for the quantitative determination of Total Bilirubin (T-BIL) in serum.

In 2020, Sysmex Corporation reached an agreement to invest in Astrego Diagnostics AB to help commercialize a rapid drug susceptibility test1 that Astrego was developing for urinary tract infections.

In 2019, Sysmex Asia Pacific Pte Ltd announced that the Company had begun providing direct sales and support in India for Haematology Business. With over 1.3 billion people, India is the world’s second most populous nation, after China, and the nation’s real GDP continues to grow significantly. In addition to robust economic advancement, India is expanding its healthcare infrastructure and improving its quality of healthcare. Sysmex valued India’s market for in vitro diagnostics at around US$800 million. Moreover, the Company expected this market to grow at a rapid annual pace of around 12-16%, as India’s healthcare infrastructure expanded and its quality of healthcare improved.

In 2022, Fujifilm India Pvt Ltd. unveiled a new range of products at the 74th National Annual Conference of IRIA 2022. The latest portfolio included a range of products offering complete and integrated solutions for diagnostic purposes, including CT, MRI, X-ray, AI, PACS, endoscopy and ultrasound systems through the Scenaria View, Supria series, The Echelon Smart and Arietta series. Offering a diverse portfolio, the new range would include solutions pertaining to CT, MRI, Digital Radiography, AI, PACS, endoscopy, IVD and ultrasound systems.

 

Market Segmentation

By product and service, the Asia Pacific in-vitro diagnostics market is segmented into:

  • Reagents and Kits
  • Instruments
  • Software and Services

By technology, the market is classified into:

  • Immunoassay/Immunochemistry
  • Clinical Chemistry 
  • Molecular Diagnostics
  • Haematology
  • Microbiology
  • Blood Glucose Self-Monitoring
  • Coagulation and Haemostasis
  • Urinalysis
  • Others

By application, the market is divided into:

  • Infectious Diseases
  • Diabetes
  • Cardiology
  • Oncology
  • Autoimmune Diseases
  • Nephrology
  • Others

By end use, the market is segmented into:

  • Hospitals
  • Laboratories
  • Homecare
  • Others

By country, the market is classified into:

  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others

 

Key Industry Players in the Market

The report presents a detailed analysis of the following key players in the Asia Pacific in-vitro diagnostics market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Sysmex Corporation
  • Medical & Biological Laboratories Co., Ltd.
  • Voxtur Bio Ltd.
  • Immulab
  • FUJIFILM Corporation
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product and Service
  • Technology
  • Application
  • End Use
  • Region
Breakup by Product and Service
  • Reagents and Kits
  • Instruments
  • Software and Services
Breakup by Technology
  • Immunoassay/Immunochemistry
  • Clinical Chemistry 
  • Molecular Diagnostics
  • Haematology
  • Microbiology
  • Blood Glucose Self-Monitoring
  • Coagulation and Haemostasis
  • Urinalysis
  • Others
Breakup by Application
  • Infectious Diseases
  • Diabetes
  • Cardiology
  • Oncology
  • Autoimmune Diseases
  • Nephrology
  • Others
Breakup by End Use
  • Hospitals
  • Laboratories
  • Homecare
  • Others
Breakup by Region
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Sysmex Corporation
  • Medical & Biological Laboratories Co., Ltd.
  • Voxtur Bio Ltd.
  • Immulab
  • FUJIFILM Corporation
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments  
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Asia Pacific
7    Industry Opportunities and Challenges
8    Asia Pacific In-Vitro Diagnostics Market Analysis

    8.1    Key Industry Highlights
    8.2    Asia Pacific In-Vitro Diagnostics Historical Market (2017-2021) 
    8.3    Asia Pacific In-Vitro Diagnostics Market Forecast (2022-2027)
    8.4    Asia Pacific In-Vitro Diagnostics Market by Product and Service
        8.4.1    Reagents and Kits
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Instruments
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Software and Services
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
    8.5    Asia Pacific In-Vitro Diagnostics Market by Technology
        8.5.1    Immunoassay/Immunochemistry
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Clinical Chemistry 
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Molecular Diagnostics
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Haematology
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Microbiology
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2017-2021)
            8.5.5.3    Forecast Trend (2022-2027)
        8.5.6    Blood Glucose Self-Monitoring
            8.5.6.1    Market Share
            8.5.6.2    Historical Trend (2017-2021)
            8.5.6.3    Forecast Trend (2022-2027)
        8.5.7    Coagulation and Haemostasis
            8.5.7.1    Market Share
            8.5.7.2    Historical Trend (2017-2021)
            8.5.7.3    Forecast Trend (2022-2027)
        8.5.8    Urinalysis
            8.5.8.1    Market Share
            8.5.8.2    Historical Trend (2017-2021)
            8.5.8.3    Forecast Trend (2022-2027)
        8.5.9    Others
    8.6    Asia Pacific In-Vitro Diagnostics Market by Application
        8.6.1    Infectious Diseases
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Diabetes
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Cardiology
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Oncology
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021)
            8.6.4.3    Forecast Trend (2022-2027)
        8.6.5    Autoimmune Diseases
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2017-2021)
            8.6.5.3    Forecast Trend (2022-2027)
        8.6.6    Nephrology
            8.6.6.1    Market Share
            8.6.6.2    Historical Trend (2017-2021)
            8.6.6.3    Forecast Trend (2022-2027)
        8.6.7    Others
    8.7    Asia Pacific In-Vitro Diagnostics Market by End Use
        8.7.1    Hospitals
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2017-2021)
            8.7.1.3    Forecast Trend (2022-2027)
        8.7.2    Laboratories
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2017-2021)
            8.7.2.3    Forecast Trend (2022-2027)
        8.7.3    Homecare
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2017-2021)
            8.7.3.3    Forecast Trend (2022-2027)
        8.7.4    Others
    8.8    Asia Pacific In-Vitro Diagnostics Market by Country
        8.8.1    Market Share
            8.8.1.1    China
            8.8.1.2    Japan
            8.8.1.3    India
            8.8.1.4    ASEAN
            8.8.1.5    Australia
            8.8.1.6    Others
9    Regional Analysis
    9.1    China
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
    9.2    Japan
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
    9.3    India
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
    9.4    ASEAN
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
    9.5    Australia
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Sysmex Corporation
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Medical & Biological Laboratories Co., Ltd.
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    Voxtur Bio Ltd.
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    Immulab
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    FUJIFILM Corporation
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Others
12    Industry Events and Developments

 

List of Key Figures and Tables

1.    Asia Pacific In-Vitro Diagnostics Market: Key Industry Highlights, 2017 and 2027
2.    Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by Product and Services (USD Million), 2017-2021
3.    Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by Product and Services (USD Million), 2022-2027
4.    Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by Technology (USD Million), 2017-2021
5.    Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by Technology (USD Million), 2022-2027
6.    Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by Application (USD Million), 2017-2021
7.    Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by Application (USD Million), 2022-2027
8.    Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by End Use (USD Million), 2017-2021
9.    Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by End Use (USD Million), 2022-2027
10.    Asia Pacific In-Vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2017-2021
11.    Asia Pacific In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Asia Pacific In-Vitro Diagnostics Market Structure.

Key Questions Answered in the Report

The market is projected to grow at a CAGR of 5.2% between 2022 and 2027.

The major drivers of the Asia Pacific in-vitro diagnostics market include the rising levels of income, rising standards of living, development of automated IVD systems for laboratories and hospitals, increasing requirement for genetic testing for personalised health care, and supportive government policies.

Expanding healthcare infrastructure and rising number of IVD (in vitro diagnostics) products being launched by key players are the key industry trends propelling the market's growth.

The major regions in the industry are China, Japan, India, ASEAN, and Australia, among others.

The various products and services in the market are reagents and kits, instruments, software and services.

Based on technology, the market is segmented into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, haematology, microbiology, blood glucose self-monitoring, coagulation and haemostasis, and urinalysis, among others.

The major applications of the market are infectious diseases, diabetes, cardiology, oncology, autoimmune diseases, and nephrology, among others.

The end-uses of the market are hospitals, laboratories, and homecare, among others.

The major players in the industry are Sysmex Corporation, Medical & Biological Laboratories Co., Ltd., Voxtur Bio Ltd., Immulab, and FUJIFILM Corporation, among others.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER